Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment

Cancer

Volumn 122, Issue 3, 2016, Pages 420-431

  Hassett, Michael J ^a,b   Schymura, Maria J ^c   Chen, Kun ^a   Boscoe, Francis P ^c   Gesten, Foster C ^c   Schrag, Deborah ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

breast cancer; disparities; Medicaid; quality

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; PRIORITY JOURNAL; RACE; SOCIAL STATUS; UNITED STATES; ASIAN AMERICAN; BREAST NEOPLASMS; CALIFORNIA; CANCER GRADING; COMPARATIVE STUDY; ECONOMICS; ETHNOLOGY; HISPANIC; MIDDLE AGED; NEW YORK; OCEANIC ANCESTRY GROUP; PATHOLOGY; REGISTER; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; BREAST NEOPLASMS; CALIFORNIA; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MEDICAID; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEW YORK; OCEANIC ANCESTRY GROUP; QUALITY OF HEALTH CARE; REGISTRIES; UNITED STATES;

EID: 84949293793     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29777     Document Type: Article

References (36)

1. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KA,. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006; 24: 626-634.
2. Moher D, Schachter HM, Mamaladze V, et al., Measuring the Quality of Breast Cancer Care in Women. Summary, Evidence Report/Technology Assessment No. 105. AHRQ Publication No. 04-E030-1. Rockville, MD: Agency for Healthcare Research and Quality; 2004.
3. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS,. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer [erratum in Ann Intern Med. 2003;139:873; summary for patients in Ann Intern Med. 2003;138:I16]. Ann Intern Med. 2003; 138: 90-97.
4. Harlan LC, Abrams J, Warren JL, Clegg L, Stevens J, Ballard-Barbash R,. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol. 2002; 20: 1809-1817.
5. Bickell NA, Wang JJ, Oluwole S, et al., Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006; 24: 1357-1362.
6. Du XL, Lin CC, Johnson NJ, Altekruse S,. Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. Cancer. 2011; 117: 3242-3251.
7. Field TS, Buist DS, Doubeni C, et al., Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005; 35: 88-95.
8. Haas JS, Earle CC, Orav JE, et al., Racial segregation and disparities in breast cancer care and mortality. Cancer. 2008; 113: 2166-2172.
9. Bigby J, Holmes MD,. Disparities across the breast cancer continuum. Cancer Causes Control. 2005; 16: 35-44.
10. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB,. Survival of blacks and whites after a cancer diagnosis [see comment]. JAMA. 2002; 287: 2106-2113.
11. Berry DA, Cronin KA, Plevritis SK, et al., Effect of screening and adjuvant therapy on mortality from breast cancer [see comment]. N Engl J Med. 2005; 353: 1784-1792.
12. Chlebowski RT, Chen Z, Anderson GL, et al., Ethnicity and breast cancer: factors influencing differences in incidence and outcome [see comment]. J Natl Cancer Inst. 2005; 97: 439-448.
13. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA,. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status [see comment]. J Clin Oncol. 2006; 24: 1342-1349.
14. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D,. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005; 294: 1765-1772.
15. American Cancer Society. Breast Cancer Facts & Figures 2011-2012. Atlanta, GA: American Cancer Society; 2011.
16. Hassett MJ, Hughes ME, Niland JC, et al., Selecting high priority quality measures for breast cancer quality improvement [see comment]. Med Care. 2008; 46: 762-770.
17. Hassett MJ, Weeks J,. Identifying high priority quality measures for breast cancer quality improvement using data from a nationally representative sample [abstract]. J Clin Oncol. 2009; 27 (15 suppl). Abstract 6507.
18. Boscoe FP, Schrag D, Chen K, Roohan PJ, Schymura MJ,. Building capacity to assess cancer care in the Medicaid population in New York State. Health Serv Res. 2011; 46: 805-820.
19. Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ,. Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data. Cancer. 2012; 118: 333-341.
20. Silva A, Rauscher GH, Ferrans CE, Hoskins K, Rao R,. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry. J Registry Manag. 2014; 41: 24-30.
21. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA,. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002; 94; 835-844.
22. Mallin K, Palis BE, Watroba N, et al., Completeness of American cancer registry treatment data: implications for quality of care research. J Am Coll Surg. 2013; 216: 428-437.
23. German RR, Wike JM, Bauer KR, et al., Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study. J Registry Manag. 2011; 38: 75-86.
24. Wolfson JA, Sun CL, Wyatt LP, Hurria A, Bhatia S,. Impact of care at comprehensive cancer centers on outcome: results from a population-based study [published online ahead of print July 28, 2015]. Cancer. doi: 10.1002/cncr.29576.
25. Inwald EC, Koller M, Klinkhammer-Schalke M, et al., Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry [published online ahead of print August 8, 2015]. J Cancer Res Clin Oncol. doi: 10.1007/s00432-015-2025-z.
26. Reeves D, Campbell SM, Adams J, Shekelle PG, Kontopantelis E, Roland MO,. Combining multiple indicators of clinical quality: an evaluation of different analytic approaches. Med Care. 2007; 45: 489-496.
27. Fiscella K, Burstin HR, Nerenz DR,. Quality measures and sociodemographic risk factors: to adjust or not to adjust. JAMA. 2014; 312: 2615-2616.
28. Yung RL, Hassett MJ, Chen K, et al., Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012; 104: 1102-1105.
29. Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H,. Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol. 2009; 27: 5160-5167.
30. Bickell NA, LePar F, Wang JJ, Leventhal H,. Lost opportunities: physicians' reasons and disparities in breast cancer treatment. J Clin Oncol. 2007; 25: 2516-2521.
31. Masi CM, Gehlert S,. Perceptions of breast cancer treatment among African-American women and men: implications for interventions. J Gen Intern Med. 2009; 24: 408-414.
32. Chen JY, Diamant AL, Thind A, Maly RC,. Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer. 2008; 112: 1153-1161.
33. Keating NL, Kouri E, He Y, Weeks JC, Winer EP,. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care. 2009; 47: 765-773.
34. Silber JH, Rosenbaum PR, Clark AS, et al., Characteristics associated with differences in survival among black and white women with breast cancer. JAMA. 2013; 310: 389-397.
35. Freedman RA, Virgo KS, He Y, et al., The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer. 2011; 117: 180-189.
36. Dohan D, Schrag D,. Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005; 104: 848-855.